SEC 13F Intelligence

Susquehanna Fundamental Investments, LLC / ALNY

Susquehanna Fundamental Investments, LLC’s Alnylam Pharmaceuticals Inc Position

Does Susquehanna Fundamental Investments, LLC own Alnylam Pharmaceuticals Inc (ALNY)? Not currently — the last reported position was 56.6K shares worth $13M in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$13M
Q4 2024
Shares
56.6K
% of Portfolio
+0.19%
Quarters Held
9
position exited

Position History ALNY

Reported value by quarter
Q3 ’20: $1MQ3 ’20Q1 ’21: $3MQ2 ’21: $1MQ2 ’21Q3 ’21: $1MQ4 ’21: $1MQ4 ’21Q1 ’22: $2MQ1 ’24: $13MQ1 ’24Q2 ’24: $14MQ4 ’24: $13MQ4 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202456.6K$13M+0.19%
Q2 202456.6K$14M+0.32%
Q1 202488.1K$13M+0.61%
Q1 202214.2K$2M+0.05%
Q4 20216.3K$1M+0.03%
Q3 20216.3K$1M+0.02%
Q2 20216.3K$1M+0.02%
Q1 202124.0K$3M+0.06%
Q3 20207.6K$1M+0.03%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Susquehanna Fundamental Investments, LLC’s full portfolio or all institutional holders of ALNY.